Willis Towers Watson (WLTW) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Achieved 6% organic revenue growth and 240 basis points of adjusted operating margin expansion year-over-year, with adjusted diluted EPS up 24% to $2.55 and free cash flow of $361 million for Q2 2024.
Revenue for Q2 2024 was $2.3 billion, up 5% year-over-year, with net income rising 48% to $142 million and adjusted net income up 20% to $263 million.
Transformation program delivered $24 million incremental annualized savings in Q2, totaling $394 million since inception, with the cumulative run rate savings target increased to $450 million by year-end.
Returned $290 million to shareholders in Q2 via $200 million in share repurchases and $90 million in dividends.
Strategic priorities advanced through specialization, talent acquisition, and operational efficiency.
Financial highlights
Q2 2024 revenue was $2.3 billion, up 5% year-over-year; adjusted operating margin was 17.0%, up 240 basis points; adjusted EBITDA margin was 20.6%, up from 19.0% in Q2 2023.
Free cash flow for the first half was $361 million, up from $350 million in the prior year; cash flows from operating activities were $431 million for Q2 2024.
Net income for Q2 2024 was $142 million, up 48% year-over-year; diluted EPS was $1.36, up 55%.
Returned $290 million to shareholders in Q2 via share repurchases and dividends; targeting $750 million in repurchases for 2024.
Foreign exchange was a $0.03 headwind to adjusted EPS for the quarter and is expected to be a $0.10 headwind for the year.
Outlook and guidance
2024 adjusted operating margin target range raised to 23.0%-23.5% and adjusted EPS to $16.00-$17.00; revenue target reaffirmed at $9.9 billion+ with mid-single-digit organic growth.
Transformation program savings target increased to ~$450 million by year-end 2024, with total cost to achieve now estimated at ~$1.175 billion.
Free cash flow margin target of 16%+ remains a longer-term goal, with incremental improvement expected as transformation spend abates.
Management expects sufficient liquidity for the next twelve months, with no mandatory debt repayments and a $1.5 billion revolving credit facility fully available.
Latest events from Willis Towers Watson
- Organic growth and margin expansion drove strong results despite divestiture impacts.WLTW
Q4 20253 Feb 2026 - Q3 saw 6% revenue growth, margin gains, and a $1.67B loss from TRANZACT sale charges.WLTW
Q3 202417 Jan 2026 - Sustained organic growth and margin expansion driven by innovation, efficiency, and portfolio optimization.WLTW
CMD 202412 Jan 2026 - 5% organic growth, margin gains, $473M savings, and $1.5B buyback planned for 2025.WLTW
Q4 20248 Jan 2026 - $1.3B acquisition leverages advanced tech and talent for $35M in synergies and U.S. growth.WLTW
M&A Announcement10 Dec 2025 - 2025 AGM to vote on directors, auditors, executive pay, share issuance, and pre-emption rights.WLTW
Proxy Filing1 Dec 2025 - Annual meeting covers director elections, pay, and auditor ratification.WLTW
Proxy Filing1 Dec 2025 - 5% organic growth and margin expansion offset TRANZACT sale; net income up 23%.WLTW
Q1 20251 Dec 2025 - Q2 2025 saw 5% organic growth, 20% EPS rise, and robust margin expansion amid strong segment results.WLTW
Q2 20255 Nov 2025